75 results about "Bloody stools" patented technology

The invention relates to the use of composition comprising free amino acids as a sole source of protein, a fatty acid source comprising long chain polyunsaturated fatty acids, a carbohydrate source comprising digestible and indigestible carbohydrates, and milk protein free Bifidobacteria for treating a person suffering from (a) colic, congestion, runny nose, wheezing, vomiting, diarrhea, bloody stools, mucus in stools, rash, eczema, gastroesophageal reflux, eosinophilic esophagitis or asthma; (b) cow's milk allergy and / or food protein intolerance; and / or (c) infections, wherein the indigestible carbohydrate is selected from a milk protein free source and the total composition is essentially free of intact proteins.

The invention discloses a traditional Chinese medicine enema for treating ulcerative colitis, wherein traditional Chinese medical science holds that the ulcerative colitis belongs to the domain of 'diarrhoea', 'bloody stool' and 'dysentery', and the pathogenesis mostly is mainly caused by feeling six viruses of wind, cold, heat, dampness and dryness, having internal damage by excess of seven emotions and damaging spleen and stomach, constraining large intestine by the dampness and heat to obstruct the intestinal Qi function and injure the vein to cause blood and meat rot to emerge ulcer finally. Therefore, the traditional Chinese medicine enema provided by the invention chooses traditional Chinese medicines including japanese claw fern herb, caulis arcangelisiae, phellodendron bark, cordate houttuynia, folium glochidii eriocarpi, featherycleft horsegentian fruit, moutan bark, frankincense, bletilla striata, red halloysite and licorice root having functions of clearing away heat and toxicity, activating blood circulation and removing blood stasis and removing swelling and promoting granulation to process into the enema. After clinical tests in the hospital, the total efficiency reaches to 97.2%, the clinical symptom improvement is obviously superior to that of a contrast group, the side effect is low and the treatment cost is low. Therefore, the enema provided by the invention is suitable for clinical promotion and application.

The invention discloses a traditional Chinese medicine composition for anti-diarrhea and anti-dysentery. The traditional Chinese medicine composition is made from the following raw materials in parts by weight: 10-15 parts of Chinese pulsatilla root, 5-10 parts of golden cypress, 10-15 parts of radix puerariae, 15-20 parts of scutellaria baicalensis, 12-18 parts of balsampear stem, 15-20 parts of potentilla discolor, 10-15 parts of coptis, 6-12 parts of licorice, 8-14 parts of roxburgh rose flower, 10-15 parts of cortex fraxini, 5-10 parts of radix paeoniae alba, 12-18 parts of angelica, 16-22 parts of elecampane, 10-15 parts of cinnamon, 5-10 parts of pomegranate leaf, 10-15 parts of selfheal, 8-14 parts of purslane, 10-15 parts of sword bean shell, 5-10 parts of humifuse euphorbia herb, 13-19 parts of rhizoma atractylodis, 10-15 parts of persicaria hydropiper, 5-10 parts of lychee exocarp, 15-20 parts of moutan bark, 18-24 parts of agastache rugosus, 10-15 parts of endothelium corneum gigeriae galli and 5-10 parts of yam. The traditional Chinese medicine composition disclosed by the invention has the functions of checking diarrhea and dysentery, invigorating spleen and supplementing qi, warming middle-Jiao and harmonizing stomach, regulating qi to alleviate pain, promoting the circulation of qi and dredging stagnation, clearing heat and promoting dieresis, and nourishing yin and cooling blood, and when being used for treating such symptoms caused by dysentery as stomachache, diarrhea, tenesmus, excretion of pus and bloody stool and the like, the traditional Chinese medicine composition is significant in effect, fast to act, quick to become effective, short in course of treatment, high in cure rate, free of toxic side effect and is safe and reliable.

The invention belongs to the technology field of traditional Chinese medicine, in particular to an enema for the treatment of radioactive rectitis, which can solve the problem that the prior art has no ideal drug and effective method for the radioactive rectitis. The enema for the treatment of the radioactive rectitis is prepared by the raw materials with the following weight ratio of 3 to 6g of sanchi, 3 to 6g of catechu, 5 to 10g of donkey-hide glue, 10 to 30g of common bletilla pseudobulb, 15 to 45g of garden burnet root, 6 to 9g of rhubarb and 15 to 30g of hairyvein agrimonia herb and bud. The enema of the invention can significantly ease mucous bloody stool, diarrhea, abdominal pain, tenesmus, anal burning pain and bearing-down pain and other clinical symptoms, improve the positive of fecal occult blood test, the colonoscopy mucous membrane lesions and the radiation injuries and improve the quality of lives of the patients; and the enema has low recurrence rate, reliable efficacy, stable function, no toxicity or side effects, thus being the more satisfied drug for the treatment of the radioactive rectitis.

The invention discloses the use of aescin in the preparation of medicine for treating ulcerative colitis. Aescin obtained from the traditional Chinese medicine Su Luozi has the functions of clearing away heat, stopping bleeding, reducing inflammation, and dispelling blood stasis, and has significant preventive and therapeutic effects on abdominal pain, diarrhea, mucus, pus, and bloody stools caused by ulcerative colitis.

The invention discloses a traditional Chinese medicine compound preparation for treating inflammatory bowel disease. The traditional Chinese medicine compound preparation comprises the following bulkdrugs in parts by weight: 2-6 parts of sargentgloryvine stem, 2-6 parts of patrinia herb, 2-6 parts of pasque flower, 2-6 parts of raw radix astragali, 2-6 parts of pseudostellaria root, and 1-5 partsof Cornus officinalis. The above traditional Chinese medicine compound preparation can be prepared to tablets, a mixture, oral liquid, a particulate agent and capsules, and has the efficacy for supplementing Qi to warming Yang, and clearing heat and expelling toxin; and is mainly used for treating inflammatory bowel disease (ulcerative colitis and Crohn's disease) large intestine damp-heat, spleen and kidney yang-deficiency, and intestinal collateral blood stasis, and is especially suitable for improving mucopurulent bloody stool, stomachache, abdominal distension, diarrhea, and rectal tenesmus. The invention also discloses a method for preparing various dosage forms of the traditional Chinese medicine compound preparation.

The invention discloses an application of aescine in preparation of a medicine for treating ulcerative colitis. The aescin obtained from the traditional Chinese medicine buckeye seeds has the effectsof clearing heat, stopping bleeding, diminishing inflammation, dissipating blood stasis and the like, and has remarkable prevention and treatment effects on symptoms such as stomachache, diarrhea, mucus abscess and bloody stool caused by the ulcerative colitis.

The invention relates to the technical field of medicine, in particular to the application of notoginseng. The invention discloses the use of notoginseng and its pharmaceutically acceptable salt or plant extract containing notoginseng in the preparation of medicines or health care products for preventing or treating ulcerative colitis. The present invention finds for the first time that panax notoginseng can significantly improve symptoms such as weight loss, bloody stool, colon shortening, and histopathological damage in mice with experimental ulcerative colitis, providing a new option for clinical treatment of ulcerative colitis, and has a good application prospect .